Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Politics

EU court weighs industry liability for costly new wastewater treatment upgrade

The European Court of Justice is reviewing a Polish challenge to a rule that would make the pharma and cosmetics sectors shoulder most of the expense for a new fourth treatment stage in municipal wastewater plants.

A lawsuit filed by Poland challenges the EU wastewater directive that obliges the pharmaceutical and cosmetics industries to fund the addition of a fourth treatment stage in municipal sewage facilities. The fourth stage, introduced in the 2024 amendment, aims to remove a wide range of micro-pollutants and must be installed in large plants and in areas supplying drinking water, with a phased rollout through 2045. Poland argues that the allocation of costs is unjustified because the industries are not responsible for many other hazardous substances and that the scientific basis for the allocation contains clear errors.

General Advocate Juliane Kokott, preparing the court's opinion, urged the judges to grant Poland's request and highlighted inconsistencies in the data used by EU bodies. Although the court initially waived an oral hearing, Kokott suggested that a hearing could clarify the disputed scientific assessments. The case joins other pending matters, including an Irish High Court reference and a dismissed claim by 33 companies, all concerning the same funding rules.

How the sides frame it

LOW AGREEMENT

Left-leaning coverage frames the case as Poland’s challenge to an unfair cost burden on industry, while centrist coverage presents the Advocate General’s recommendation as a victory for the pharmaceutical sector and emphasizes projected cost savings.

LEFT

Poland’s lawsuit is portrayed as exposing unjustified cost allocation and data inconsistencies in the EU directive.

CENTER

The Advocate General’s recommendation is portrayed as a win for pharma and a cost-saving measure for Europe.

The left emphasises

  • Poland argues the allocation of costs is unjustified because industries are not responsible for many other hazardous substances
  • General Advocate Juliane Kokott urged judges to grant Poland's request
  • Highlights inconsistencies in the data used by EU bodies
Get the beta ↗